Following approval by CRG, GMMMG, and the Greater Manchester ICS Clinical Effectiveness and Governance Committee, the formulary and RAG list have been updated as follows:

  • Avatrombopag for primary chronic immune thrombocytopenia added to chapter 9 as a RED drug
  • Esketamine nasal spray for treatment-resistant depression added to DNP list

The formulary has also been updated to reflect relevant safety alerts and NICE guidelines. For full details, see the formulary change log available on the formulary page.